Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0VHHWJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
OBI-998
|
|||||
| Synonyms |
OBI 998; OBI998
Click to Show/Hide
|
|||||
| Organization |
OBI Pharma, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Non-small cell lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Antibody Name |
OBI-898
|
Antibody Info | ||||
| Antigen Name |
Stage-specific embryonic antigen-4 (SSEA-4)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Maleimide and PEGylated cleavable linker
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.